These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 7674830)
21. The discovery of PD 89211 and related compounds: selective dopamine D4 receptor antagonists. Pugsley TA; Shih YH; Whetzel SZ; Zoski K; Van Leeuwen D; Akunne H; Mackenzie R; Heffner TG; Wustrow D; Wise LD Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):219-26. PubMed ID: 11817497 [TBL] [Abstract][Full Text] [Related]
22. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168 [TBL] [Abstract][Full Text] [Related]
23. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively. Urwyler S; Markstein R J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868 [TBL] [Abstract][Full Text] [Related]
25. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase. Makman MH; Dvorkin B Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967 [TBL] [Abstract][Full Text] [Related]
26. [3H](+)S 14297: a novel, selective radioligand at cloned human dopamine D3 receptors. Newman-Tancredi A; Audinot V; Jacques V; Peglion JL; Millan MJ Neuropharmacology; 1995 Dec; 34(12):1693-6. PubMed ID: 8788967 [TBL] [Abstract][Full Text] [Related]
27. The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease. Scheller D; Ullmer C; Berkels R; Gwarek M; Lübbert H Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):73-86. PubMed ID: 18704368 [TBL] [Abstract][Full Text] [Related]
28. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy. Millan MJ; Peglion JL; Vian J; Rivet JM; Brocco M; Gobert A; Newman-Tancredi A; Dacquet C; Bervoets K; Girardon S J Pharmacol Exp Ther; 1995 Nov; 275(2):885-98. PubMed ID: 7473180 [TBL] [Abstract][Full Text] [Related]
30. Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626. Bowery BJ; Razzaque Z; Emms F; Patel S; Freedman S; Bristow L; Kulagowski J; Seabrook GR Br J Pharmacol; 1996 Dec; 119(7):1491-7. PubMed ID: 8968560 [TBL] [Abstract][Full Text] [Related]
31. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. Audinot V; Newman-Tancredi A; Gobert A; Rivet JM; Brocco M; Lejeune F; Gluck L; Desposte I; Bervoets K; Dekeyne A; Millan MJ J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337 [TBL] [Abstract][Full Text] [Related]
32. [3H]nemonapride and [3H]spiperone label equivalent numbers of D2 and D3 dopamine receptors in a range of tissues and under different conditions. Vile JM; D'Souza UM; Strange PG J Neurochem; 1995 Feb; 64(2):940-3. PubMed ID: 7830089 [TBL] [Abstract][Full Text] [Related]
33. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain. Gackenheimer SL; Schaus JM; Gehlert DR J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534 [TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of D1 and D2 dopamine receptors in cultured neuroblastoma and retinoblastoma clonal cell lines. Monsma FJ; Brassard DL; Sibley DR Brain Res; 1989 Jul; 492(1-2):314-24. PubMed ID: 2665904 [TBL] [Abstract][Full Text] [Related]
37. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells. Barton AC; Black LE; Sibley DR Mol Pharmacol; 1991 May; 39(5):650-8. PubMed ID: 1674585 [TBL] [Abstract][Full Text] [Related]
38. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist. Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660 [TBL] [Abstract][Full Text] [Related]
39. Expression and pharmacological characterization of the human D3 dopamine receptor. Freedman SB; Patel S; Marwood R; Emms F; Seabrook GR; Knowles MR; McAllister G J Pharmacol Exp Ther; 1994 Jan; 268(1):417-26. PubMed ID: 8301582 [TBL] [Abstract][Full Text] [Related]